Genexol-PM is a novel anti-cancer formulation of paclitaxel, a well-known chemotherapeutic agent. Unlike conventional paclitaxel, which is dissolved in a solvent that can cause severe side effects, Genexol-PM uses a polymeric micelle delivery system, which enhances the solubility of paclitaxel and reduces the risk of adverse reactions.
